EP3M Summit 2026 Brings Together Biopharma Leaders to Advance Portfolio Strategy, Decision Intelligence, and Innovation Portfolio Management

▤ Summary

Cambridge Healthtech Institute has opened registration for the 2026 EP3M Summit in Boston and online. The event focuses on portfolio strategy, governance, analytics, prioritization, and decision intelligence for pharmaceutical and biotech leaders. This year’s program adds an interactive workshop on making R&D investment decisions under uncertainty and highlights AI, competitive intelligence, and portfolio optimization. Speakers and participants come from major life sciences companies including Novartis, Biogen, AbbVie, Bristol Myers Squibb, Eli Lilly, and Sanofi. The summit is aimed at improving how R&D organizations allocate resources and make strategic portfolio decisions.

▦ Linked Companies